Microcystin-LR induces apoptosis in L-02 cell line.
- Author:
La-mei LEI
1
;
Li-rong SONG
;
Bo-ping HAN
Author Information
- Publication Type:Journal Article
- MeSH: Apoptosis; drug effects; Cell Line; Hepatocytes; cytology; Humans; Microcystins; toxicity; Proto-Oncogene Proteins c-bcl-2; biosynthesis; genetics; Tumor Suppressor Protein p53; biosynthesis; genetics
- From: Journal of Southern Medical University 2006;26(4):386-389
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the toxicological mechanism of microcystin-LR (MCLR) on L-02 cells.
METHODSL-02 cells was treated with MCLR at different concentrations and the subsequent changes such as cell proliferation (MTT assay), morphology, lactate dehydrogenase (LDH) leakage, apoptosis rate and apoptosis-related gene expression were examined.
RESULTSMTT assay showed that MCLR mildly inhibited the cell growth within the initial 24 h of treatment but enhanced the cell viability after that till 60 h in a time- and dose-dependent manner. LDH leakage underwent no marked changes in response to 48-hour MCLR treatment but increased upon prolonged treatment for 60 h, indicating the presence of oxidative damage. After a 48-h treatment with MCLR at 50 microg/ml, obvious apoptosis of L-02 cells occurred as manifested by cell rounding, detachment from the substrate, cell shrinkage and membrane blebbing. The apoptosis rates were rather low (between 22% and 29%) after treatment with MCLR at different concentrations for 36 h, and increased to as much as 80% after a 60-h treatment with 50 microg/ml MCLR. The expressions of p53 and bcl-2 increased in the cells after treatment with high-concentration MCLR, suggesting that MCLR up-regulated the expression levels of the two proteins.
CONCLUSIONMCLR can induce apoptosis and up-regulate p53 and bcl-2 expressions in human normal liver cell line L-02.